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Host cells develop the OAS/RNase L [2′–5′–oligoadenylate synthetase (OAS)/ribonu-
clease L] system to degrade cellular and viral RNA, and/or the OASL/RIG-I (2′–5′–OAS 
like/retinoic acid inducible protein I) system to enhance RIG-I-mediated IFN induction, 
thus providing the first line of defense against viral infection. The 2′–5′–OAS-like (OASL) 
protein may activate the OAS/RNase L system using its typical OAS-like domain (OLD) 
or mimic the K63-linked pUb to enhance antiviral activity of the OASL/RIG-I system 
using its two tandem ubiquitin-like domains (UBLs). We first describe that divergent 
avian (duck and ostrich) OASL inhibit the replication of a broad range of RNA viruses 
by activating and magnifying the OAS/RNase L pathway in a UBL-dependent manner. 
This is in sharp contrast to mammalian enzymatic OASL, which activates and magnifies 
the OAS/RNase L pathway in a UBL-independent manner, similar to 2′–5′–oligoade-
nylate synthetase 1 (OAS1). We further show that both avian and mammalian OASL 
can reversibly exchange to activate and magnify the OAS/RNase L and OASL/RIG-I 
system by introducing only three key residues, suggesting that ancient OASL possess 
2–5A [px5′A(2′p5′A)n; x = 1-3; n ≥ 2] activity and has functionally switched to the OASL/
RIG-I pathway recently. Our findings indicate the molecular mechanisms involved in the 
switching of avian and mammalian OASL molecules to activate and enhance the OAS/
RNase L and OASL/RIG-I pathways in response to infection by RNA viruses.
Keywords: birds, mammals, Oasl, Oas/rnase l pathway, Oasl/rig-i pathway
inTrODUcTiOn
RNA viruses pose large challenges to human health and animal production with high mutation rates, 
rapid replication kinetics, and complex evolutionary dynamics (1, 2). To defend against virus infec-
tions, the host cellular innate immune system recognizes pathogen-associated molecular patterns 
with various pattern recognition receptors and activates a rapid antiviral response. After which, 
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host cells secrete interferons (IFNs) to activate and stimulate a cas-
cade of pathways for antiviral factors, including hundreds of IFN-
stimulated genes (ISGs) (3, 4). Among ISGs, 2′–5′-oligoadenylate 
synthetase (OAS) plays a critical role in antiviral immunity by 
synthesizing 2–5As, which induces RNA degradation by activa-
ting a latent RNase (RNase L) pathway (5, 6).
The OAS repertoire is classed into four subfamilies that encode 
proteins of different isoforms in Metazoa. The small isoform [2′–5′- 
oligoadenylate synthetase 1 (OAS1)] consists of one copy of the enzy-
matic OAS domain, whereas the medium (OAS2) and large (OAS3) 
isoforms have one or two additional non-enzymatic OAS-like 
domains (OLDs) in the N-terminus. OASL presents an enzy matic 
(e.g., mouse Oasl2, mOasl2) or non-enzymatic OLD domain (e.g., 
human OASL, hOASL; mouse Oasl1, mOasl1) in the N-terminus 
and two tandem ubiquitin-like domains (UBLs) in the C-terminus 
(7–9). Recent evolutionary analyses suggested that adaptive selec-
tions to circumvent viral-encoded inhibitors in the OAS gene 
family have driven their functional diversity (10, 11). For example, 
all OAS subfamilies (OAS1-3) synthesize 2–5As to activate RNase 
L upon binding dsRNA (12, 13). However, OAS1 prefers to bind 
cytosolic dsRNA with fewer than 20 bp and a 3′-single-stranded 
pyrimidine motif (5), whereas OAS3 has a strong ability to bind 
long dsRNA (>50 bp) (12). Such adaptive change is even signi-
ficant in the OASL subfamily, where the non-enzymatic hOASL 
mediates RIG-I activation to inhibit virus replication by mim-
icking polyubiquitin and upregulating the exp ression of IFNβ, 
TNFα, and IL-8, whereas the ortholog of hOASL in mouse (the 
non-enzymatic mOasl1) negatively regulates antiviral immunity 
by inhibiting the translation of IFN-regulatory factor 7 (IRF7) 
(14, 15). Moreover, the paralog of hOASL in mouse (mOasl2) 
synthesizes 2–5As activates RNase L and induces rRNA degra-
dation after detecting dsRNA, similar to OAS1-3 (9).
Compared to mammals, birds have a contractive OAS family, 
which contains one member (OASL) in most birds belonging to 
the Carinatae group (e.g., ducks) and two members (OAS1 and 
OASL) in a few birds belonging to the Ratitae group (e.g., ostriches). 
Sequence alignment of 22 avian OASL molecules showed that 
they hold three conserved aspartic acid (D, homologous to D75-
D77-D148 in human OAS1) residues, which serve as metal ion 
ligands and are required to activate the enzymatic activity to syn-
thesize 2–5As (16). However, whether and how birds (especially 
Carinataes) can recognize divergent RNA viruses to activate the 
OAS/RNase L system and/or enhance the OASL/RIG-I system 
using one OAS member (OASL) (where mammals do it with a 
functionally diverse OAS family), is largely unknown.
Here, we find that avian OASLs activate and enhance the 
OAS/RNase L pathway to inhibit replication of a positive single-
stranded RNA virus, two strains of double-stranded RNA viruses, 
and four strains of negative single-stranded RNA viruses, which 
requires both their OLD and UBL domains. This differs from the 
situation in mammals, where one mammalian OASL (mOasl2) 
and one mammalian OASL mutant (hOASL-3D) activate and 
mag nify the OAS/RNase L pathway to inhibit viral replication 
with their OLD domains like OAS1 (Figure 1). Upon introduc tion 
of mutations at three D residues homologous to D75-D77-D148 
of hOAS1, avian OASL-3D*, and mOasl2-3D* lose the ability 
to synthesize 2–5As, enhance the RIG-I antiviral activation, 
and upregulate the expression of many genes downstream of 
RIG-I in a virus- and UBL-dependent manner, similarly to hOASL 
(Figure  1). These results indicated that avian and mammalian 
OASLs could be an effective target for alternative regulation of the 
OAS/RNase L and OASL/RIG-I pathways during viral infection.
resUlTs
Duck and Ostrich Oasl Proteins lead to 
resistance to infection by a Broad range 
of rna Viruses
Duck RIG-I can detect influenza A virus and induces an anti-
viral response in chicken embryonic fibroblasts (DF1) cells, where 
the RIG-I is absent (17). To determine the role of avian OASL in 
the immune response, we compared viral replication of a highly 
pathogenic (A/duck/Hubei/49/05, DK/49) and a weakly patho-
genic (A/goose/Hubei/65/05, GS/65) H5N1 virus in DF1 cells 
expressing duck OASL (DF1dOASL+/+) to the corresponding in duck 
RIG-I recovery-expression DF1 cells (DF1dRIG-I+/+). Interestingly, 
DF1dOASL+/+ and DF1dRIG-I+/+ cells showed comparatively lower levels 
of DK/49 and GS/65 virus titers compared to DF1 cells express-
ing empty vectors, supporting that duck OASL can efficiently 
prevent viral infection, similarly to duck RIG-I (Figures 2A,B). 
We further found that DF1dOASL+/+ cells have a reduced expression 
of the matrix gene vRNA and mRNA of the DK/49 virus using 
a strand-specific real-time RT-PCR methods (18), implying that 
the dOASL may affect virus transport and transcription (Figure S1 
in Supplementary Material). We then generated OASL-deficient 
DF1 cells (DF1OASL−/−) using the CRISPR/Cas9-mediated genome 
editing method (Figure S2 in Supplementary Material) (19). As 
expected, DF1dOASL+/+ cells had a significantly lower level of the 
CK/0513 (A chicken/huabei/0513/2007) H5N1 virus, whereas 
DF1OASL−/− cells showed a significantly higher level of the CK/0513 
virus compared to DF1 cells expressing an empty vector (Figure 2C). 
Similarly, we found that ostrich OASL (oOASL), representing 
ancient avian OASLs (20), significantly inhibited the replication 
of CK/0513 virus in DF1 cells (Figure 2D; Figure S1 in Supple-
mentary Material), supporting that avian OASLs play a critical 
role in the immune response to influenza A viruses, similarly to 
some mammalian OASLs.
We next investigated the antiviral activity of avian OASLs 
against diverse viruses. Interestingly, the expression of either 
dOASL or oOASL in DF1 cells significantly reduced the replica-
tion of another negative single-stranded RNA virus (Newcastle 
disease virus, NDV/La Sota) and two double-stranded RNA viruses 
(infectious bursal disease virus, IBDV/B87 and respiratory enteric 
orphan virus, REOV/Z97/C10). In contrast, the absence of OASL 
in DF1 cells significantly enhanced the viral replication of the 
above three viruses (Figures 2E–J). Further analysis indicated that 
dOASL inhibited the replication of a positive single-stranded RNA 
virus (Foot-and-mouth disease virus, FMDV/O/Mya) in por cine 
kidney cells (IBRS2) (Figure 2K). However, neither dOASL nor 
oOASL reduced replication of two strains of double-stranded 
DNA virus in DF1 cells (fowlpox virus, FPV/CVCC/AV1003) 
or in porcine kidney epithelial (PK15) cells (pseudorabies virus, 
PRV/Henan/2014) (Figure S3 in Supplementary Material). 
FigUre 1 | Domain organizations, purification, and expression in cells of duck, ostrich, human, and mouse OASL proteins and their mutants. (a) Schematic 
diagram of OASLs, their mutants and truncations. Red, green, and black letter in OLD domain mean amino acids being homologous to D75-D77-D148, R195-
K199-K205, and C331-F332-K333 (CFK motif) of human 2′–5′-oligoadenylate synthetase 1, respectively. (B) Western blot analyses of OASLs, their mutants and 
truncations in DF1 (duck and ostrich) or A549 (human and mouse) cells (up), and His-tagged recombinant proteins (down). Western blot analysis was detected 
using Flag or c-Myc antibody. GAPDH (1:5,000) was used as a protein loading control. The purified proteins were analyzed by SDS-PAGE.
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Taken together, avian OASL shows antiviral activity against a wide 
range of RNA viruses but not against DNA viruses.
Duck and Ostrich Oasl Proteins activate 
and Magnify the Oas/rnase l Pathway to 
induce Viral rna Degradation similarly to 
Mouse Oasl2
To investigate whether avian OASL activates the OAS/RNase L 
pathway to decay viral RNA, we first examined the 2–5A synthesis 
activities of duck (58 kDa) and ostrich (60 kDa) recombinant OASL 
proteins through a heat-inactivated 2–5A synthetase reaction. 
As expected, both dOASL and oOASL produced superimposed 
elution profiles with more than three peaks using poly(I:C) (pIC) 
as an activator, supporting that avian OASL synthesizes dimeric 
(pppApA), trimeric (pppApApA), and longer oligomers like human 
OAS1 (hOAS1) and mOasl2 (Figure 3A). Among four types of 
tested divalent cations, Mg2+ and Mn2+ stimulated the 2–5A acti-
vity of dOASL at a high level, whereas Zn2+ and Ca2+ stimulated 
this activity only at a low level (Figure 3B). Furthermore, both low 
(an average size of 0.2–1 kb) and high (an average size of 1.5–8 kb) 
weight pIC stimulated the 2–5A activity of dOASL and oOASL 
at a high level (Figure 3C), while poly(dA:dT) (pAT, a surrogate 
for dsDNA viruses) stimulated the 2–5A activity of dOASL and 
oOASL at a low level (Figures 3D,E).
To test whether avian OASL activates RNase L to degrade RNA 
with their 2–5A products, we examined the rRNA integrity in dif-
ferent DF1 cells using a rRNA cleavage assay after induction with 
FigUre 2 | Duck and ostrich OASL proteins inhibit a broad range of RNA virus replications and the loss of chicken OASL enhances these RNA virus replications.  
Cells infected with virus were harvested at the indicated time points and subjected to EID50 assays or TCID50 assays on MDCK, DF1, Vero, or BHK21 cells (two–tailed 
Student’s t-test, n = 3). The data are expressed as the mean ± SD. *P < 0.05; **P < 0.01. (a,B) DF1dOASL+/+ cells have fewer DK/49 (a) and GS/65 (B) virus. DF1dRIG-I+/+ 
cells were a positive control for antiviral activity. (c) DF1dOASL+/+ cells exhibited lower level than NC cells, while DF1OASL−/− (chicken OASL-deficient DF1) cells had higher 
level than wild-type DF1 cells, of CK/0513 virus. NC is chicken DF1 cell expressing empty vector. (D) DF1 cells expressing oOASL exhibited lower level of CK/0513 
virus titers. (e–g) DF1dOASL+/+ cells produced fewer, while DF1OASL−/− cells had more replication of NDV (e), IBDV (F), and REOV (g) virus. (h–J) DF1 cells expressing 
oOASL showed a severe reduction in virus titers of NDV (h), IBDV (i), and REOV (J) virus. (K) IBRS2 cells expressing dOASL had significantly lower FMDV virus titer.
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pIC. Expectedly, parental DF1 cells and both dOASL or oOASL 
recovery-expression DF1OASL−/−cells (transfected with dOASL 
or oOASL) had a low rRNA integrity number (RIN 6.9–7.4), 
whereas DF1OASL−/− cells had a high RIN (10.0) (Figure  3F). 
This was similar to the case in mammals, in which A549 cells 
(human alveolar basal epithelial cells) expressing mOasl2 had a 
low RIN (6.0), and parental A549 cells (containing OAS1-3) had 
a relatively high RIN (7.6) (Figure 4H). Similarly, parental DF1 
cells, dOASL and oOASL recovery-expression DF1OASL−/− and 
A549 cells expressing mOasl2 had a low RIN (8.0, 8.2, 8.0, and 
7.3, respectively) after being infected by CK/0513 or PR8 viruses. 
DF1OASL−/− cells did not induce rRNA degradation and had a high 
RIN (10.0) (Figures 3F and 4I). In summary, these data support 
that avian OASLs possess 2–5A synthetase activity and activate 
the OAS/RNase L pathway to inhibit the replication of a range of 
RNA viruses.
Similar to OASL, RNase L was also known as an ISG (21). Pre-
vious studies indicated that exposure of human prostate cancer 
cells DU145 to physiologic levels of 2–5A (0.1  M) produces a 
remarkable transcription of ISG (i.e., ISG15) (22). We, therefore, 
asked whether OASL enhances the activation of OAS/RNase L 
signaling to prevent viral infection. Interestingly, we found that 
both dOASL and oOASL significantly increased the expression of 
RNase L and 10 of 16 genes (IRF1, IRF7, IFNα, IFNβ, IFNAR1, 
JAK1, STAT1, MX1, PKR, and TNFα) related to IFN signaling in 
DF1 OASL−/− cells induced by the CK/0513 virus (Figures  3G–I). 
Similarly, mOasl2 significantly enhanced the expression of RNase L 
and six (IRF3, IFNα, IFNβ, IFIT1, IL8, and TNFα) of 10 tested genes 
related to IFN signaling in A549 cells after infection by the PR8 
virus (Figures  4J–L). These observations supported that enzy-
matic OASLs enhance OAS/RNase L signaling to degrade viral 
RNA and magnify IFN signaling to defend against viral infection.
Duck and Ostrich Oasl reversibly switch 
off Their 2–5a activity similarly to human 
Oasl and Mouse Oasl2 When Mutations 
Were introduced at Three conserved D 
residues
Previous studies have indicated that three D sites (homologous 
to D75-D77-D148 in hOAS1) that serve as metal ion ligands are 
required to synthesize 2–5As (23, 24). To test the effects of these 
FigUre 3 | Duck and ostrich OASL proteins synthesize 2–5A to activate and enhance the OAS/RNase L pathway degrading cellular and viral RNA. The 2–5A 
synthetase reaction was treated with alkaline phosphatase and separated using a Mono Q column. hOAS1 was a positive control for 2–5A activity. Numbers in the 
elution profiles of A–E represent adenylate, pppApA, pppA(pA)2, pppA(pA)3, pppA(pA)4, pppA(pA)5, pppA(pA)6, respectively. NC is chicken OASL-deficient DF1 cell 
expressing empty vector. WT is parent DF1 cell. “RIN” is the RNA integrity number. Gene expressions were calculated relative mRNA level to that of GAPDH and 
presented as fold change against the corresponding of NC without CK/0513 infection (two-tailed Student’s t-test, n = 3). The data are expressed as the mean ± SD. 
*P < 0.05; **P < 0.01. (a–e) 2–5As produced by dOASL or oOASL with pIC (a), dOASL with different divalent cations (B), dOASL with HMW or LMW (c), dOASL 
with pAT (D), oOASL with pAT (e). (F) rRNA cleavage induced by dOASL or oOASL in DF1OASL−/− cells transfected with pIC (5 µg/mL) for 4 h or infected with 
CK/0513 (multiplicity of infection = 1) for 18 h. (g–i) dOASL and oOASL significantly increased the expression of RNase L (g) and 10 genes (h,i) related to IFN 
signaling after infection with CK/0513 virus in DF1OASL−/− cells, respectively.
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three D residues on the binding affinity for the dsRNA and 2–5A 
activity of OASLs, we introduced mutations at the homologous 
sites of the above three D residues to generate dOASL, oOASL, 
mOasl2, and hOASL mutants. Interestingly, the mutations of the 
three D residues switched off the 2–5A activity of the OASLs, 
but seem not to affect their binding affinity for pIC (Figure S4 
in Supplementary Material). For example, dOASL-3D*, oOASL-
3D*, and mOasl2-3D* lost their 2–5A activity, whereas hOASL-
3D recovered 2–5A activity (Figures  4A–C). Detailed analysis 
indicated that after losing the 2–5A activity, neither dOASL-3D* 
nor oOASL-3D* induced rRNA degradation or upregulated 
the expression of RNase L or the 16 other genes related to IFN 
FigUre 4 | Three conserved sites of duck, ostrich, human, and mouse OASL being homologous to D75-D77-D148 of human 2′–5′-oligoadenylate synthetase 1 
are a button for switching on/off the OAS/RNase L pathway. The 2–5A synthetase reaction was treated with alkaline phosphatase and separated using a Mono Q 
column. Gene expression in cells were calculated relative mRNA level to that of GAPDH and presented as fold change against the corresponding of A549 cells 
expressing empty vector (NC) without PR8 virus infection (two-tailed Student’s t test, n = 3). The data are expressed as the mean ± SD. *P < 0.05; **P < 0.01. 
(a–c) The elution profiles produced by dOASL-3D* or oOASL-3D* (a), mOasl2 or mOasl2-3D* (B), and hOASL-3D or hOASL proteins (c). (D,e) dOASL-3D* and 
oOASL-3D* did not inhibit the DK/59 and GS/65 in DF1 cells (D) or CK/0513 (e) virus replication in DF1OASL−/− cells, whose RIG-I is naturally absent. (F,g) 
hOASL-3D and mOasl2 slightly or significantly inhibited the replication of PR8 [multiplicity of infection (MOI) = 0.001] virus in A549 (F) or HeLa (g) cells. (h,i) rRNA 
cleavage induced by hOASL-3D and mOasl2 in A549 cells stimulated with pIC (h) (500 ng/mL) or infected with PR8 virus (i) MOI = 1. (J–l) hOASL-3D and mOasl2 
significantly increased the expression of RNase L (J) and six genes (K,l) related to IFN signaling upon infection with PR8 virus (MOI = 0.001).
6
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signaling, thus failing to prevent virus infection in DF1 cells and 
DF1OASL−/− (Figures 4D,E; Figures S5 and S6 in Supplementary 
Material). However, nonenzymic mOasl2-3D* failed to induce rRNA 
degradation and upregulate expression of RNase L, but signifi-
cantly inhibited PR8 virus replication in A549 and HeLa (human 
cervical carcinoma) cells (Figures 4F–L). Moreover, similarly to 
mOasl2, the expression of hOASL-3D inhibited the PR8 virus 
replication in both A549 and HeLa cells, induced rRNA degrada-
tion when inoculated with either pIC (500 ng/mL) or the PR8 
virus (MOI = 1), and increased the expression of RNase L, IRF3, 
7Rong et al. Antiviral Mechanisms of OASL Gene
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IFNα, IFNβ, IFIT1, IL8, and TNFα in A549 cells (Figures 4F–K). 
In summary, these observations suggest that avian and mamma-
lian enzymatic and non-enzymatic OASLs can reversibly change 
the role in the immune response to viral infection through editing 
three metal ion ligand sites homologous to D75-D77-D148 in 
hOAS1.
Unlike the OlDs of Mouse Oasl2 and 
human Oasl Mutant (Oasl-3D), Those  
of Duck and Ostrich cannot efficiently 
activate the Oas/rnase l Pathway
To identify domains that are critical for antiviral activity of OASL 
proteins, we created Flag-tagged truncations of dOASL, oOASL, 
hOALS-3D, and mOasl2 that lacked one (Δ1UBL) or two UBLs 
(OLD) (Figure 1). Interestingly, like the above four enzymatic full 
length OASLs, two avian and two mammalian truncations lack-
ing one UBLs (Δd1UBL, Δo1UBL, Δh1UBL-3D, and Δm1Ubl) 
could significantly inhibit one or two H5N1 virus replications 
through binding dsRNA to synthesize 2–5As and induce rRNA 
degradation, upregulate expression of RNase L and nine (IRF1, 
IRF7, IFNα, IFNβ, IFNAR1, JAK1, STAT1, MX1, and PKR) or 
five (IRF3, IFNα, IFNβ, IFIT1 and TNFα) other genes related to 
IFN signaling in DF1OASL−/− or A549 cells (Figure 5; Figures S7 
and S8 in Supplementary Material). Similarly, two mammalian 
truncations (hOLD-3D and mOld) lacking both UBLs could 
bind dsRNA to synthesize 2–5As and induce rRNA degradation, 
upregulate expression of RNase L and four other genes related to 
IFN signaling (IRF3, IFNα, IFNβ, and IFIT1), efficiently activate 
and enhance the OAS/RNase L to inhibit PR8 virus replication in 
A549 cells (Figure 6; Figure S8 in Supplementary Material). In 
sharp contrast, two avian truncations (dOLD and oOLD) lacking 
both UBLs neither induce rRNA degradation (Figures 5D,E) nor 
upregulate expression of RNase L and genes related to IFN signal-
ing (Figure 5F; Figure S7 in Supplementary Material), thus failing 
to block one or two H5N1 virus replications in the DF1OASL−/− and 
DF1 cells (Figures 5A–C). Detailed analysis indicated that dOLD 
and oOLD bound dsRNA, but failed to synthesize longer oligom-
ers of 2–5Aswith pIC as an activator (Figure 5D; Figure S4 in 
Supplementary Material). Previous studies demonstrated that a 
tripeptide motif (CFK) within human OAS1 and OAS2 mediates 
polymerization and affects the synthesis of effective 2–5As (25). 
We then asked whether mutations in the CFK motif of avian 
OLD affect their polymerization and further influence their 
processivity for 2–5A synthesis. We introduced a CFK motif of 
hOAS1 at a homologous site of dOLD to generate dOLD-CFK*1 
and dOLD-CFK*2 substitutions (Figure 1). Unexpectedly, upon 
Mn2+ stimulation and pIC, neither dOLD-CFK*1 nor dOLD-
CFK*2 synthesized trimeric or longer oligomers. In contrast, the 
mOld-CIT* substitution containing the CFK motif of dOASL, 
also synthesized trimeric or longer oligomers, like mOld did 
(Figure S8C in Supplementary Material). These results suggest 
that avian OLDs diverged substantially from both mammalian 
OAS1 and mammalian OLDs, thus it cannot restore the 2–5A 
activity of avian OLDs efficiently through the compensation of a 
conserved CFK motif.
Duck and Ostrich UBls in Oasls,  
but not human Oasl Mutant (Oasl-3D) 
and Mouse Oasl2 Ones, Bind dsrna  
and are required to activate the Oas/
rnase l Pathway
Upon discovering that the UBLs of avian OASLs are essential 
to exert their antiviral activity, we generated Flag-tagged two-
tandem UBL truncations of two avian and mammalian OASLs 
to investigate their functions in the OAS/RNase L pathway 
(Figure 1). As expected, the two avian (dUBL and oUBL) and two 
mammalian (hUBL and mUbl) truncations failed to synthesize 
2–5As (data not shown), induce rRNA degradation, and change 
the expression of RNase L and genes related to IFN signaling when 
treated with pIC or infection with H5N1 virus (DK/49, GS/65, 
CK/0513, or PR8), thus failing to inhibit H5N1 virus replication 
in DF1 and DF1OASL−/− or A549 cells (Figure S9 in Supplementary 
Material). These results suggest that the tandem UBLs of avian 
and mammalian OASLs have no antiviral activity and cannot 
activate the OAS/RNase L pathway.
Previous studies showed that upon binding dsRNA, OAS 
synthesizes 2–5As, which in turn activates RNase L to trigger 
antiviral activity (23, 26, 27). As avian OASLs synthesized short 
oligomers of 2–5A and failed to activate the OAS/RNase L 
pathway when their two tandem UBL domains were deleted, we 
asked whether UBLs improve the 2–5A activity of avian OASLs 
by enhancing their binding affinity to dsRNA. As expected, 
dOLD had a lower binding affinity for pIC compared to that of 
the full protein. However, both mOLD and hOLD-3D showed a 
comparative level of binding affinity for pIC to their full proteins 
(Figure S4 in Supplementary Material). Further binding affinity 
analysis demonstrated that the UBLs of dOASL and oOASLs, but 
not that of hOASL and mOASL2, bound pIC (Figures S4 and S9 
in Supplementary Material). Thus, our data show that the UBL of 
avian OASLs, but not mammalian OASLs, enhance the binding 
affinity of OASL to dsRNA and are essential to activate the OAS/
RNase L pathway.
Duck and Ostrich Oasl Mutants  
(Oasl-3D*) enhance rig-i signaling  
in a similar Manner to human Oasl  
and Mouse Oasl2 Mutant (Oasl2-3D*)
Recent studies have shown that hOASL reduced a broad range 
of virus replications through enhancing the RIG-I activation 
(14, 28, 29). Similarly, hOASL and mOasl2-3D* failed to activate 
and magnify the OAS/RNase L system, but significantly inhibited 
PR8 virus replication in A549 cells (Figure 6A). We, therefore, 
asked whether both avian and mammalian non-enzymatic OASLs 
or enzymatic OASL mutants utilize the RIG-I pathway to inhibit 
viral replication. We generated an additional dOASL mutant 
(dOASL-3K*) through introducing mutations at three conserved 
positively charged amino acids (K) in the dsRNA-binding groove 
(Figure 1) (23). As expected, although binding dsRNA, dOASL-
3K* together with the other two avian OASL mutants (dOASL-
3D* and oOASL-3D*) lacked 2–5A activities and did not activate 
FigUre 5 | Duck and ostrich OASL activate and magnify the OAS/RNase L pathway in a ubiquitin-like domains (UBL)-dependent manner, while human OASL-3D 
and mouse Oasl2 do it in a UBL-independent manner. Cells infected with virus were collected at indicated time points to perform EID50 assays or TCID50 assays 
on MDCK cells. NC is DF1, DF1OASL−/−, or A549 cells expressing empty vector. The 2–5A synthetase reaction was treated with alkaline phosphatase and separated 
using a Mono Q column. “RIN” is the RNA integrity number (n = 3). The data are expressed as the mean ± SD. *P < 0.05; **P < 0.01. (a–c) Truncations of dOASL 
and oOASL lacking one UBL, but not lacking both UBLs, significantly inhibited DK/49 (a) and GS/65 (B) virus replications in DF1 cells or CK/0513 (c) virus 
replications in DF1OASL−/− cells. (D) The elution profiles produced by truncations and truncated mutants of four enzymatic OASL lacking one UBL and two UBLs in 
reaction. (e) rRNA cleavage induced by truncations of dOASL and oOASL in DF1OASL−/− cells transfected with pIC for 4 h or CK/0513 virus (multiplicity of 
infection = 1) for 18 h. (F) Truncations of dOASL and oOASL lacking one UBL, but not lacking two UBLs, significantly increased the expression of RNase L upon 
infection with CK/0513 virus in DF1OASL−/− cells.
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RNase L to degrade rRNA, failing to prevent virus infection in 
DF1 and DF1OASL−/− cells (Figures  4D,E; Figures S5 and S6 in 
Supplementary Material). Because RIG-I is absent in chickens, 
this observation is similar to hOASL, which showed no antiviral 
activity in the absence of RIG-I (17, 29). Interestingly, dOASL-3D* 
and oOASL-3D*, but not dOASL, oOASL, and dOASL-3K*, sig-
nificantly enhanced the dRIG-I activation to reduce the CK/0513 virus 
replication in duck RIG-I recovery-expression DF1OASL−/− cells. 
FigUre 6 | Duck and ostrich OASL-3D* interact with RIG-I and enhance the RIG-I signaling in a ubiquitin-like domains (UBL)-dependent manner, similarly to human 
OASL and mouse Oasl2-3D*. Cells infected with virus were harvested at the indicated time points and subjected to EID50 or TCID50 assays on MDCK cells. NC is 
DF1OASL−/− or A549 cells expressing empty vector. Gene expressions in cells were calculated relative mRNA level to that of GAPDH and presented as fold change 
against the corresponding of NC without virus infection (two-tailed Student’s t-test, n = 3). The data are expressed as the mean ± SD. *P < 0.05; **P < 0.01. 
(a,g,h) hOASL and mOasl2-3D*, but not their truncations, significantly increase expression of six genes downstream of MAVS and inhibit PR8 virus replication in 
A549 cells after infection at 48 h. (B–F) Like hOASL and mOasl2-3D*, dOASL-3D* and oOASL-3D*, but not their truncations enhance the antiviral effect of dRIG-I 
and increased expression of nine genes downstream of MAVS in the dRIG-I recovery DF1OASL−/− cells upon CK/0513 infection. (i–K) Full length, mutants, and 
truncations (except UBL) of dOASL, hOASL, and mOasl2 co-precipitate with dRIG-I before and after infected by CK/0513 or PR8 virus. (l) Yeast two-hybrid 
analysis shows that dOASL-3D*, but not dOASL and hOASL, directly interacted with dRIG-I and hRIG-I proteins.
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This observation is similar to the case in mammals, where one non-
enzymatic (hOASL) and one enzymatic OASL mutant (mOasl2-
3D*) significantly enhanced the RIG-I activation, while their 
enzymatic OASL proteins (hOASL-3D and mOasl2) and another 
non-enzymatic mutant (hOASL-R*K*K*) did not (Figures 6A–C; 
Figures S10 and S11 in Supplementary Material). Further analysis 
indicated that all truncations of dOASL-3D*, oOASL-3D*, hOASL, 
and mOasl2-3D* lacking one or two UBLs failed to reduce the 
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CK/0513 and PR8 virus replication in duck RIG-I recovery-
expression DF1OASL−/− or A549 cells (Figures 6A,D).
RIG-I targets MAVS to initiate downstream signaling, thereby 
inducing the transcription of type I IFNs and ISGs. We next 
evaluated whether OASL-3D* induced the expression of RIG-I 
signaling. Expectedly, both dOASL-3D* and oOASL-3D*, but not 
dOASL, oOASL, and dOASL-3K*, significantly increased the exp-
ression of nine genes (IRF1, IFNα, IFNβ, IFNAR1, JAK1, STAT1, 
MX1, PKR, and TNFα) downstream of MAVS after infecting 
by CK/0513 virus (Figures 6E,F; Figure S10 in Supplementary 
Material). Whereas neither avian OASL nor their mutants affe-
cted the expression of MAVS, MDA5, and LGP2 in duck RIG-I 
recovery-expression DF1OASL−/− cells (data not shown). Similarly, 
two mammalian non-enzymatic OASL proteins (hOASL and 
mOasl2-3D*), but not their enzymatic OASL proteins, significantly 
increased the expression of five genes in the RIG-I signaling path-
way (IRF3, IFNα, IFNβ, IFIT1, and IL8) in A549 cells infected 
with the PR8 virus (Figures 6G,H; Figure S11 in Supplementary 
Material). We further compared the gene expression of the RIG-I 
pathway in duck RIG-I recovery-expression DF1OASL−/− cells and 
A549 cells that expressed truncations lacking one or two UBLs 
of dOASL-3D*, hOASL, or mOasl2-3D*. This effort found that 
none of them changed the expression of the above tested genes 
of the RIG-I signaling pathway with or without IAV infection 
(Figures 6E–H), further supporting that OLD and the two UBLs 
of avian and mammalian OASLs are essential for magnifying the 
RIG-I pathway.
We then investigated the interaction between RIG-I and OASL 
and found that both dOASL and dOASL-3D* co-precipitated with 
dRIG-I in DF1 cells before and after infection with the CK/0513 
virus (Figures 6I,J). Similarly, we observed that hOASL, mOasl2, 
and their mutants (hOASL-3D and mOasl2-3D*) co-precipitated 
with human or mouse RIG-I in 293T  cells (Figure  6K). Thus, 
the mutation of the three conserved D residues did not affect the 
interaction between OASL and RIG-I. Detailed analysis indicated 
that UBL-deleted OASL (Δh1UBL, hOLD, Δm1Ubl, and mOld) 
and their corresponding mutants (Δd1UBL-3D*, dOLD-3D*, 
Δh1UBL-3D, hOLD-3D, Δm1Ubl-3D*, and mOld-3D*) also 
interacted with RIG-I, whereas the UBL of OASL alone (dUBL, 
hUBL, and mUBL) did not (Figures  6J,K). This observation, 
combined with that truncations of avian and mammalian non-
enzymatic OASL proteins, did not prevent against virus infection, 
indicates that the OLD domain of OASL is sufficient to mediate 
the interaction between OASL and RIG-I but insufficient to 
enhance RIG-I signaling. We further investigated the module of 
this interaction using a yeast two-hybrid system. This effort found 
that among the above OASLs and their mutants from ducks and 
humans, only dOASL-3D* directly interacted with intact duck 
and human RIG-I protein (Figure 6L).
DiscUssiOn
Here, we first demonstrated that, after stimulation by dsRNA, 
two divergent avian OASLs (dOASL and oOASL) activated RNase 
L to induce rRNA degradation using their 2–5A products like 
mammalian enzymatic OASL (mOasl2) (Figures  3 and 7). We 
find that three conserved D residues were crucial to adaptively 
reversible switching between enzymatic and non-enzymatic 
OASL, where mutants of one mammalian (mOasl2) and two avian 
enzymatic OASL (dOASL and oOASL) lose their 2–5A activity and 
mutant of one mammalian non-enzymatic OASL (hOASL-3D) 
recover its 2–5A activity. We also found that two avian (dOASL 
and oOASL) and two mammalian (hOASL-3D and mOasl2) enzy-
matic OASLs significantly increased the expression of RNase L 
and 10 (IRF1, IRF7, IFNα, IFNβ, IFNAR1, JAK1, STAT1, MX1, 
PKR, and TNFα) or six (IRF3, IFNα, IFNβ, IFIT1, IL8, and TNFα) 
genes related to IFN signaling in DF1OASL−/− cells or in A549 cells 
after infection with the H5N1 (CK/0513 or PR8) virus (Figures 3 
and 4). This is consistent with the fact that 2–5A induces the gene 
expression of several ISGs (P56, P54, IL8, and ISG15) in DU145 
prostate cancer cells and HeLa cells (22). Therefore, our observa-
tions support to the theory that the ancient OASL of birds and 
mammals possessed 2–5A activity and executed their antiviral 
activity through activating and magnifying the OAS/RNase L 
pathway and enhancing IFN signaling. Moreover, our functional 
analyses strengthen the idea that species-specific adaptations 
appear to accelerate the functional divergence of the OASL 
molecules. For example, avian OASLs developed a UBL-dependent 
manner to activate and magnify the RNase L system and IFN 
signaling to block virus replication. In this UBL-dependent 
model, the OLDs of avian OASLs bind dsRNA and synthesize 
2–5As, but cannot activate RNase L to degrade rRNA and inhibit 
virus replication (Figures 5 and 7). The UBLs of avian OASLs bind 
dsRNA like their OLDs, and truncations of avian OASLs lacking 
both UBLs showed weak binding affinity for dsRNA (Figures S4 
and S9 in Supplementary Material). These observations, together 
with the abnormality in the 2–5A synthesis activity of dOLD and 
oOLD (Figure 5), supported the idea that UBLs of avian OASLs 
have been optimized to bind dsRNA using their enriched positive 
amino acids (A, H, and L). This optimization, in return, improved 
avian OASLs’ polymerization and processivity for 2–5A synthesis 
and contributed to the activation and magnification of RNase L 
signaling. We then hypothesized that avian OASLs could bind 
dsRNA with different lengths and showed antiviral activity to a 
range of viruses. This hypothesis was supported by our data. Such 
as, both dOASL and oOASL synthesized 2–5As at high level after 
induction with either low or high weight pIC and significantly 
inhibited the replication of two strains of double-stranded (IBDV/
B87 and REOV/Z97/C10) and four strains of negative single-
stranded (DK/49, GS/65, CK/0513, and NDV/La Sota) RNA 
viruses (Figures 2 and 3). Additionally, dOASL protected against 
a strain of positive single-stranded (FMDV/O/Mya) RNA virus 
infection in IBRS2 cells (Figure 2). For mammalian enzymatic 
OASLs (hOASL-3D and mOasl2), they activate and magnify the 
RNase L system and IFN signaling to block virus replication in 
a UBL-independent manner like hOAS1 (30). In this case, both 
hOLD-3D and mOld could activate RNase L to decay rRNA with 
their 2–5A products, magnify the RNase L and IFN signaling, 
and inhibit the PR8 virus replication (Figure 5). Since the UBLs 
of hOASL-3D and mOasl2 did not bind dsRNA, they appear to 
be functionally redundant for the activation and magnification of 
the OAS/RNase L system (Figure S4 in Supplementary Material).
Upon detecting viral dsRNA, mammalian enzymatic OASLs 
activate RNase L to induce the endonucleolytic cleavage of viral 
FigUre 7 | Model of avian and mammalian OASL involvement in RNase L and RIG-I signaling. As a sensor, ancient and enzymatic OASL in birds and mammals 
contain three aspartic acids (D), which are homologous to D75-D77-D148 in hOAS1 and required to synthesize 2–5As, and three key positively charged amino 
acids (R/K-K/R-K), which are homologous to R195-K199-K205 in human 2′–5′-oligoadenylate synthetase 1 (OAS1). Both avian and mammalian OASLs develop the 
potential ability to switch the OAS/RNase L and OASL/RIG-I signaling. In natural, avian OASL activates and magnifies the OAS/RNase L pathway to exert antiviral 
activity in an UBL-dependent manner, where both its OAS-like domain (OLD) and UBL domains bind dsRNA. While some enzymatic mammalian OASLs activate 
and magnify the OAS/RNase L pathway to exert antiviral activity in an UBL-independent manner, where only their OLD domains bind dsRNA and synthesizes 2–5A 
like human OAS1. Some non-enzymatic mammalian OASLs lose 2–5A activity, switch to activate, and enhance RIG-I signaling to inhibit the replications of RNA 
viruses in a UBL-dependent manner when their three conserved D sites are mutated. Such natural switching between the OAS/RNase L and OASL/RIG-I using 
OASL molecules were recently, thus, both avian and mammalian OASL may reversibly to activate and magnify one of the above signaling when we introduce 
mutations at three conserved D sites. Five-pointed star (red): D residue; Five-pointed star (blue): D sites serving as metal ion ligands were mutated to A residue, or 
E81, E83, and T152 site in hOASL; Four-pointed star (black): three key positively charged amino acids; Four-pointed star (green): three key positively charged amino 
acids (RKK or KKK) were mutated to E. Abbreviations: OLD, OAS-like domain; UBL, ubiquitin-like domain; ARD, ankyrin repeat domain; KEN, kinase-extension-
nuclease domain; CARD, caspase activation and recruitment domain; CTD, carboxy-terminal domain; ISRE, interferon-stimulated response element; MAVS, 
mitochondrial antiviral signaling protein; IRF, IFN-regulatory factor; ssRNA, single-stranded RNA; dsRNA, double-stranded RNA.
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and cellular ssRNAs using their 2–5A products (21, 24, 25), while 
some mammalian non-enzymatic OASLs (such as human OASL) 
cannot synthesize 2–5A and activate RNase L to degrade viral and 
cellular ssRNAs, but can mediate RIG-I activation by mimicking 
polyubiquitin to inhibit virus replication (14, 29). Interestingly, 
we found that such natural switching between the OAS/RNase 
L and OASL/RIG-I signaling are reversible and mediated by 
three crucial D residues in birds and mammals. When mutations 
were introduced at three conserved D residues homologous to 
D75-D77-D148 of hOAS1, two avian (dOASL-3D* and oOASL-
3D*) and one mammalian (mOasl2-3D*) OASL mutants lost 
2–5A activity and changed to enhance the RIG-I signaling-like 
hOASL did (Figures 4 and 7; Figures S9 and S11 in Supplementary 
Material). In contrast, one mammalian OASL mutant (hOASL-
3D) restored 2–5A activity, activated and magnified the OAS/
RNase L pathway like two avian and one mammalian enzymatic 
OASL did (dOASL, oOASL, and mOsl2) (Figures 3 and 4). How-
ever, when mutations were introduced at three conserved K (or R) 
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residues homologous to R195-K199-K205 of hOAS1 in the dsRNA- 
binding groove (Figure 1) (23, 31), dOASL and hOASL mutants 
(dOASL-3K* and hOASL-R*K*K*) activated and magnified 
neither the OAS/RNase L nor the RIG-I pathway (Figures S6 and 
S10 in Supplementary Material). These observations suggested 
that three conserved D residues in the OLD of OASL acted as a 
switch for the adaptive exchange between the OAS/RNase L and 
RIG-I pathways, while three positively charged K (or R) residues 
in the dsRNA-binding groove of OASLs are essential to both the 
OAS/RNase L and RIG-I pathways. Moreover, we found that two 
tandem UBL domains were required for avian and mammalian 
non-enzymatic OASLs (dOASL-3D*, oOASL-3D*, hOASL, and 
mOasl2-3D*) to enhance and magnify the RIG-I pathway, even they 
interacted with RIG-I in a UBL-independent manner (Figure 6; 
Figure S10 in Supplementary Material). The UBL of hOASL was 
reported to mediate its specific interaction with methyl CpG-
binding protein 1 (MBD1), which is an ISG and functions as a 
transcriptional repressor (32). However, manually querying the 
MBD1 repertoire against the non-redundant database in NCBI 
and examining avian genome assemblies in Ensembl (release 87) 
indicated that MBD1 appears to be absent in birds (data not 
shown). Thus, avian OASLs may not enhance the RNase L, IFN, and 
RIG-I signaling by binding the MBD1 protein.
Mouse Oasl1 specifically suppresses IRF7 translation by bind-
ing to a double stem-loop structure in its 5’UTR, thus negatively 
regulates IFN during viral infection (15). We found that, unlike 
mOasl1, dOASL did not suppress IRF7 translation through 
binding its 5’UTR (Figure S12 in Supplementary Material). This 
finding is consistent with our observation that avian OASLs 
slightly or significantly increase the expression of IRF7 and then 
significantly upregulate the expression of IFNα and IFNβ in 
DF1OASL−/−cells infected by the CK/0513 virus (Figure 3). Birds, 
therefore, do not present a negative feedback pathway for the 
IFN response through OASL like some mammals (i.e., mouse). In 
the future, our ability to describe the structure of OASL protein 
using cryo-electron microscopy and to identify target proteins 
or RNAs through immunoprecipitation combined with high 
throughput sequencing will extend our knowledge about the role 
of OASL in the activation and regulation of RNase L and IFN 
signaling as well as RIG-I signaling.
MaTerials anD MeThODs
Facility and ethics statement
Studies of one H1N1 (A/Puerto Rico/8/34, PR8) and three H5N1 
viruses (A/duck/Hubei/49/05, DK/49; A/goose/Hubei/65/05, 
GS/65; A chicken/huabei/0513/2007, CK/0513) were conducted 
in a biosecurity level 3+ laboratory approved by Chinese Ministry 
of Agriculture or China Agricultural University. The NDV/La 
Sota, IBDV/B87, REOV/Z97/C10, FPV/CVCC/AV1003, PRV/
Henan/2014, and FMDV/O/Mya viruses were maintained in a 
biosecurity level 2+ laboratory approved by China Institute of 
Veterinary Drug Control or Lanzhou Veterinary Research Insti tute. 
The age of 10 days (10-day-old) chicken embryos were obtained 
from Hualan Chen’s lab, and chicken embryos studies were 
approved by the Review Board of Harbin Veterinary Research 
Institute, Chinese Academy of Agricultural Sciences.
cell culture and Viral infections
DF1 (Chicken embryonic fibroblasts cells), 293T (human embry-
onic kidney 293T cells), A549 (human alveolar basal epithelial cells), 
HeLa (human cervical carcinoma cells), Vero (African green monkey 
kidney cells), MDCK (Madin-Darby canine kidney cells), BHK21 
(baby hamster kidney fibroblast cells), and C2C12 (murine myo-
blast cells) were purchased from American Type Culture Colle-
ction. PK15 (porcine kidney epithelial cells) and IBRS2 (porcine 
kidney cells) were obtained from the Cell Resource Center, Peking 
Union Medical College. All the above cells were maintained in 
Dulbecco’s modified Eagle’s medium supplemented with 10% fetal 
bovine serum (FBS; Gibco, Carlsbad, CA, USA) in an atmosphere 
of 5% CO2 at 37°C. Viruses were propagated in 10-day-old chicken 
embryos. Three samples of cells inoculated with a multiplicity of 
infection (MOI) of 0.1, 0.01, or 0.001 with one of the above virus 
after 6, 12, 18, 24, 36, 48, 60, and/or 72 h were collected to moni-
tor virus replication. Titers were calculated by the egg infectious 
dose (EID50) individuals using the Reed and Muench method 
(DK/49, GS/65, and NDV), monitored tissue culture infective 
dose (TCID50) of the cytopathic effect of end-point dilutions 
(CK/0513, PR8, IBDV, REOV, PRV, and FMDV), or quantified 
through quantitative PCR with the primer listed in Table S1 in 
Supplementary Material (FPV).
construction and expression of 
recombinant Plasmids
The coding sequences of dOASL, dRIG-I, oOASL, and mOasl2 
were amplified from whole duck lungs infected with the DK/49 
virus, an whole ostrich spleen cDNA library or C2C12 cells 
according their gene sequences (KC869660.1, XM_009673088, 
and NM_011854) using the primers in Table S2 in Supplementary 
Material (33, 34). Truncations and mutants of dOASL, oOASL, 
hOASL, and mOasl2 were generated using specific PCR and site-
directed mutagenesis, respectively (Tables S2–S4 in Supplementary 
Material). Full-length, truncated and mutant dOASL, dRIG-I, 
oOASL, hRIG-I, and mRig-i were cloned individually into the 
piggyBac (containing a Flag-tag) (35), pCMV-Myc, or pCMV-HA 
vectors (Clontech, Mountain View, CA, USA) (Tables S2–S4 in 
Supplementary Material) and were transfected to cells using Lipo-
fectamine 3000 (Thermo Fisher, Carlsbad, CA, USA). Gene 
expression in cells was examined by Western blotting using the 
anti-Flag, anti-Myc or anti-HA antibody (1:1,000).
establishment of Oasl-Deficient  
DF1 cells
DF1 cells were co-transfected with Cas9 nuclease and sgRNA plas-
mids, subjected to trypsin digestion and limiting dilutions using 
methods similarly to those applied to human cells (19). Clones with 
large fragment deletion and biallelic mutations in targeted genes 
were selected through PCR using gene-specific primers covering 
the region targeted by sgRNA, and they were subsequently confirmed 
by sequencing (Tables S5 and S6 in Supplementary Material).
Protein Purification, Detection of 2–5a 
activity, and dsrna-Binding affinity
Full length, truncated and mutant of OASLs with an affinity 
 His-tag were cloned into the pET-28a(+) vector using the primers 
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in Tables S3 and S4 in Supplementary Material, and transformed 
into Escherichia coli BL21 Codon Plus RIPL (TransGen, Beijing, 
China) cells. Bacteria were induced to express OASL protein 
by the addition of 0.5–1.0  mM isopropyl-β-d-thiogalactoside 
overnight at 18–25°C and were lysed in 25  mL of buffer A 
using an AvestinEmulsiFlex C3 (Avestin, Ottawa, ON, Canada). 
Thereafter, the recombinant proteins were isolated using Ni2+-
NTA affinity column chromatography and further purified with 
a Heparin HiTrap (5  mL) column (GE Healthcare, Uppsala, 
Sweden). The 2–5A activity of the recombinant proteins was 
detected using Mono Q purification, similarly to that applied to 
mOasl1 and mOasl2 (9). Binding affinity of OASL proteins to 
dsRNA were evaluated using an Octet RED platform (ForteBio, 
Menlo Park, CA, USA). The affinities were derived by fitting the 
kinetic data to a 1:1 Langmuir binding model utilizing global 
fitting algorithms (36). The dissociation constants KD, K on 
(association rate), and K off (dissociation rate) were determined 




Cells were transfected with equal amounts of Flag- and/or 
Myc-tagged recombinant plasmids (8  µg) or 3 ×  Flag-tagged 
recombinant plasmids (15 µg) using Lipofectamine 3000 reagents 
(Thermo Fisher, Carlsbad, CA, USA) and lysed in IP lysis buffer 
(Beyotime, Beijing, China) containing a final concentration 
of 1  mM PMSF (Beyotime, Beijing, China) after transfection 
for 24 h. The lysate was cleared using protein A + G agarose 
(Beyotime, Beijing, China) and specific IgG for 3  h at 4°C 
and then incubated with anti-Flag immunoglobulin (1:1,000; 
Abcam, Cambridge, MA, USA) and protein A +  G agarose 
overnight at 4°C. After that, the immunoprecipitated proteins 
were analyzed using SDS-PAGE following silver staining and 
a liquid chromatography-mass spectrometry (LC-MS, Q-TOF) 
assay in BGI-Beijing or Western blotting using a mouse mono-
clonal c-Myc antibody (1:1,000; Clontech, Mountain View, CA, 
USA).
Yeast Two-hybrid analysis
Full-length RIG-I were cloned into the bait vector pGBKT7 
to create fusion proteins with the Gal4 DNA-binding domain 
and OASL proteins were individually cloned into the prey 
vector pGADT7. Both recombinant bait and prey vectors were 
transformed into the S. cerevisiae host strain AH109 using 
the lithium acetate/polyethylene glycol method (Clontech, 
Mountain View, CA, USA). Positive clones in which the 
expressed prey protein interacted with the bait protein were 
selected on minimal double-dropout medium (lacking L and 
W), assessed on triple selection plates (lacking L, W, and H), 
and patched onto plates with higher stringency quadruple-
dropout medium (without L, W, H, and Adenine). Primers 
used for the yeast two-hybrid analysis are listed in Table S7 in 
Supplementary Material.
Quantitative rT-Pcr and rrna  
cleavage assay
Total RNA was isolated from cells using the RNeasy Plus Mini 
Kit (Qiagen, Hilden, Germany) or TRIzol (Invitrogen, Rockville, 
MD, USA) reagent. Then, RNA was DNase-treated (Qiagen, 
Hilden, Germany) and resolved on RNA chips using an Agilent 
2100 BioAnalyzer. RNA integrity was assessed by RIN score (37). 
cDNA was synthesized with Oligo(dT)18 primer or gene-specific 
primers using the Promega Improm-II reverse transcriptase 
(Promega, Madison, WI, USA) and used to examine gene 
expression using primers in Table S1 in Supplementary Material 
through normalizing the corresponding expression of the 
GAPDH reference gene. Gene differential expression between 
samples was calculated using 2 −ΔΔCT method (38).
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